Your browser doesn't support javascript.
loading
Does renal mass biopsy influence multidisciplinary treatment recommendations?
Lobo, Jennifer M; Clements, Matthew B; Bitner, Daniel P; Mikula, Matthew D; Noona, Sean W; Sultan, Mark I; Cathro, Helen P; Lambert, Drew L; Schenkman, Noah S; Krupski, Tracey L.
Afiliación
  • Lobo JM; Department of Public Health Sciences, University of Virginia, Charlottesville, VA, USA.
  • Clements MB; Department of Urology, University of Virginia, Charlottesville, VA, USA.
  • Bitner DP; Department of Urology, University of Virginia, Charlottesville, VA, USA.
  • Mikula MD; Department of Urology, University of Virginia, Charlottesville, VA, USA.
  • Noona SW; Department of Urology, University of Virginia, Charlottesville, VA, USA.
  • Sultan MI; Department of Urology, University of Virginia, Charlottesville, VA, USA.
  • Cathro HP; Department of Pathology, University of Virginia, Charlottesville, VA, USA.
  • Lambert DL; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA.
  • Schenkman NS; Department of Urology, University of Virginia, Charlottesville, VA, USA.
  • Krupski TL; Department of Urology, University of Virginia, Charlottesville, VA, USA.
Scand J Urol ; 54(1): 27-32, 2020 Feb.
Article en En | MEDLINE | ID: mdl-31868063
Purpose: To examine how a multidisciplinary team approach incorporating renal mass biopsy (RMB) into decision making changes the management strategy.Methods: A multidisciplinary team comprised of a radiology proceduralist, a pathologist and urologists convened monthly for renal mass conference with a structured presentation of patient demographics, co-mborbidities, tumor pathology, laboratory and radiographic features. Biopsy protocol was standardized to an 18-gauge core needle biopsy using a sheathed apparatus under renal ultrasound guidance. Biopsy diagnostic rate, and concordance with nephrectomy specimens were summarized. Descriptive statistics were used to evaluate influence of RMB on management decisions.Results: A total of 83 patients with a ≤4 cm mass were discussed, and 66% of patients underwent RMB. Of those, 87% were diagnostic with 9% of core biopsies showing benign pathology. Active surveillance (AS) was recommended for 34% of patients with biopsy data as compared to 64% of those without biopsy. Ablation was recommended for 38% of the biopsy cohort compared to 7% without biopsy. Partial nephrectomy rates were similar for both cohorts, approximately 17% and 22%, respectively. Our complication rate was 1.5%, with only 1 Clavien-Dindo Grade 2 complication. Histology was concordant in 93% of patients that ultimately underwent partial nephrectomy after biopsy.Conclusions: Over half of our SRM patients underwent a RMB that provided a diagnosis in 85% of cases. RMB aided in shared decision making by providing insight into the biology of renal masses, which helps to guide multidisciplinary management and consideration of nephron sparing options.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Angiomiolipoma / Adenoma Oxifílico / Técnicas de Ablación / Espera Vigilante / Toma de Decisiones Clínicas / Neoplasias Renales / Nefrectomía Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Scand J Urol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Angiomiolipoma / Adenoma Oxifílico / Técnicas de Ablación / Espera Vigilante / Toma de Decisiones Clínicas / Neoplasias Renales / Nefrectomía Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Scand J Urol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suecia